Maynard Um
-
-
-
-
-
-
-
Barinthus Biotherapeutics plc (BRNS) Misses Q2 EPS by 16c
-
-
-
-
-
-
-
Arbutus Biopharma (ABUS) and Barinthus Bio (BRNS) Announce New Data from the IM-PROVE II Trial Showing that the Addition of Nivolumab Increased Rates of HBsAg Loss in People with Chronic Hepatitis B
-
-
-
-
-
-
-
Barinthus Biotherapeutics (BRNS) Announces Strategic Pipeline Prioritization Following Positive Interim Data from VTP-300 in Chronic Hepatitis B Virus Infections
433,311 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

